Alterity Therapeutics Limited (ATHE)

Alterity Therapeutics Revenue

In the fiscal year ending June 30, 2024, Alterity Therapeutics had annual revenue of 4.02M AUD with 2.63% growth. Alterity Therapeutics had revenue of 2.12M in the half year ending June 30, 2024, a decrease of -23.36%.

• Revenue (ttm): 4.02M AUD
• Revenue Growth: +2.63%
• P/S Ratio: 14.36
• Revenue / Employee: 401,929 AUD
• Employees: 10
• Market Cap: 38.51M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	4.02M	102.95K	2.63%
Jun 30, 2023	3.92M	-1.21M	-23.56%
Jun 30, 2022	5.12M	783.93K	18.06%
Jun 30, 2021	4.34M	-	-
Jun 30, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.